Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin added to rosuvastatin in women with polycystic ovary syndrome
ACTRN12612000663853Phase 4Recruiting
- Sponsor
- American University of Beirut
- Start
- Jul 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in polycystic ovary syndrome (PCOS) comparing Rosuvastatin followed by rosuvastatin + metformin with Rosuvastatin followed by rosuvastatin + placebo (2 arms). Primary endpoint: Change in inflammatory markers. Started Jul 2011; status: recruiting.
02
Drugs
rosuvastatinmetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ACTRN12612000663853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000663853.